CAG Recap & More

Conagra Brands, Inc. CAG – Recap 

With the markets ripping again yesterday, one of the options ideas we had zeroed in on produced some really nice gain opportunities for us. We signaled the CAG 07/02 $33.50-34.50 Calls, and two out of three of those contracts logged double-bag gains on the day.

Here are the total ranges and possible profits that these calls provided:

CAG 07/02 $33.50-34.50 Calls
$33.50: 1.15-2.15 (+87%)
$34: .77-1.76 (+129%)
$34.50: .55-1.35 (+145%)

______

Fresh Ideas:
FDX 07/02 $149-155 Calls
STZ 07/02 $175-180 Calls



OncoCyte Corp. OCX

On OCX yesterday, we noticed a drastic change as the stock fell off a cliff on news that it would discontinue development of its DetermaDx liquid biopsy test. Purely from a technical perspective, we have to take notice when a stock gets chopped by half and falls to near annual lows in one session.

It leaves a lot of future opportunity for a bounceback on the table, so we’re going to signal a long term idea in the options chain, and begin monitoring the OCX 11/20 $2.50 Calls.


Extended Watchlist:
ERFB, ARGQ, LFER, PVHO, XALL